Purpose/Objective: ARISTOTLE is a UK NCRI phase III trial comparing standard versus novel chemo-radiotherapy as pre-operative treatment for MRI defined locally advanced rectal cancer. The pre-trial radiotherapy quality assurance (RTQA) process for ARISTOTLE is aimed at ensuring that participating centres comply with the outlining, planning and reporting standards required by the trial protocol. This paper summarises the initial results from the pre-trial RTQA assessments for participating centres. Materials and Methods: The main requirements of the pre-trial QA process are trial questionnaires, outlining and planning benchmark cases, process document and case submission. Specific aspects include the following. Outlining Exercise. A reference CT dataset is provided for outlining. Participants are required to outline adhering to protocol and utilising naming conventions. It is a requirement that each RT centre returns at least one outlining benchmark case, reviewed and approved by the local Principal Investigator. Planning Cases. Two planning benchmark cases are supplied, with volumes pre-delineatedone prone and one supine. Centres are requested to plan the example relating to the position they intend to use for trial patients. Planning is required to be performed as per protocol, with attention paid to the dose volume objectives for both target coverage and maximum patient doses. Planning QA includes submission and evaluation of a Plan Assessment Form using standardised metrics for reporting, which is completed and returned for the planning case. Results: Forty UK radiotherapy centres have participated in the QA process so far, with full QA completed for 32. Some centres returned planning cases from more than one clinician. The total number of cases returned to date is 40. Reports were submitted to participating centres when QA was completed, with specific dialogue to clarify and address points of uncertainty. Initial review of QA reports received to date suggests some evidence of protocol mis-interpretation with respect to the following. Outlining. Ipsilateral obturator internus (required to be outlined within CTV by protocol) not included by 11 clinicians of the 40 who have submitted to date. The contralateral obturator internus (not required to be outlined within CTV by protocol) was included by 5 clinicians.
